Crop vaccination without side effects: optimising the cost-benefit balance of chemically induced immune priming in greenhouse vegetables.

无副作用的作物疫苗接种:优化温室蔬菜化学诱导免疫启动的成本效益平衡。

基本信息

  • 批准号:
    BB/P006698/1
  • 负责人:
  • 金额:
    $ 75.35万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2017
  • 资助国家:
    英国
  • 起止时间:
    2017 至 无数据
  • 项目状态:
    已结题

项目摘要

It is possible that over half of the crops cultivated each year are lost to pests and diseases. The use of chemical pesticides helps to reduce these losses, but many pesticides are becoming less efficient as diseases develop resistance, and others are being removed from the market because of fears that they might affect the environment or human health. The objective of our project is to develop a different approach to protecting crops by boosting their own immune system. This strategy, known as chemically induced immune priming, has been used to protect some crops against commercially important diseases, including grey mould and downy mildew. However, the commercialisation of these resistance-inducing chemicals has not been successful, because they often also repress plant growth. A recent breakthrough by our research team showed that it is possible to separate the resistance-inducing effects of the chemical priming agent beta-aminobutyric acid (BABA) from its growth repressing effects. Although BABA protects plants against an exceptionally wide range of commercially relevant diseases, it also stunts plant growth and affects crop yield when applied at higher doses. Recently, we discovered that the receptor for BABA controls disease resistance and the accompanying plant stress response via separate signalling pathways (Luna et al. 2014; Nature Chemical Biology 10: 450 - 456). The current project aims to translate these research findings from the model system (Arabidopsis) to vegetable crops (tomato and lettuce). The international plant breeding company Enza Zaden, one of the world's largest suppliers of vegetable seeds to farmers, are so excited about the opportunity to enhance the benefits of immune priming that they have offered to make their research materials available to us and to co-fund our work. Together, we have designed an entirely novel project to optimize chemically-induced immune priming in vegetable crops, using an integrated approach of genetic and chemical strategies to reduce input of pesticides in the vegetable industry. If successful, our approach can be used effectively to protect vegetable crops in a more sustainable manner from damaging diseases.
每年种植的作物可能有一半以上因病虫害而损失。化学杀虫剂的使用有助于减少这些损失,但随着疾病产生抗药性,许多杀虫剂的效率越来越低,其他杀虫剂因担心它们可能影响环境或人类健康而退出市场。我们项目的目标是开发一种不同的方法,通过增强作物自身的免疫系统来保护作物。这种策略被称为化学诱导免疫引发,已用于保护某些作物免受商业上重要的疾病,包括灰霉病和霜霉病。然而,这些抗性诱导化学品的商业化并不成功,因为它们通常也抑制植物生长。我们研究小组最近的一项突破表明,有可能将化学引发剂β-氨基丁酸(BABA)的抗性诱导作用与其生长抑制作用分开。虽然BABA保护植物免受非常广泛的商业相关疾病的侵害,但当以较高剂量施用时,它也会阻碍植物生长并影响作物产量。最近,我们发现BABA的受体通过单独的信号传导途径控制抗病性和伴随的植物胁迫反应(Luna等人,2014; Nature Chemical Biology 10:450 - 456)。目前的项目旨在将这些研究结果从模式系统(拟南芥)转化为蔬菜作物(番茄和生菜)。国际植物育种公司Enza Zagreb是世界上最大的农民蔬菜种子供应商之一,他们对有机会提高免疫启动的益处感到非常兴奋,他们提出向我们提供他们的研究材料,并共同资助我们的工作。我们共同设计了一个全新的项目,以优化蔬菜作物中化学诱导的免疫启动,使用遗传和化学策略的综合方法来减少蔬菜行业中的农药投入。如果成功,我们的方法可以有效地用于以更可持续的方式保护蔬菜作物免受破坏性疾病的侵害。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A rapid and non-destructive method for spatial-temporal quantification of colonization by Pseudomonas syringae pv. tomato DC3000 in Arabidopsis and tomato.
  • DOI:
    10.1186/s13007-021-00826-2
  • 发表时间:
    2021-12-13
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Furci L;Pascual-Pardo D;Ton J
  • 通讯作者:
    Ton J
Immune priming in plants: from the onset to transgenerational maintenance.
  • DOI:
    10.1042/ebc20210082
  • 发表时间:
    2022-09-30
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
  • 通讯作者:
Costs and Benefits of Transgenerational Induced Resistance in Arabidopsis.
  • DOI:
    10.3389/fpls.2021.644999
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
    López Sánchez A;Pascual-Pardo D;Furci L;Roberts MR;Ton J
  • 通讯作者:
    Ton J
Prospects for plant defence activators and biocontrol in IPM - Concepts and lessons learnt so far
  • DOI:
    10.1016/j.cropro.2016.10.003
  • 发表时间:
    2017-07-01
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Bruce, Toby J. A.;Smart, Lesley E.;Ton, Jurriaan
  • 通讯作者:
    Ton, Jurriaan
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jurriaan Ton其他文献

Heritability Of Rhizobacteria-mediated Induced Systemic Resistance And Basal Resistance In Arabidopsis
  • DOI:
    10.1023/a:1008743809840
  • 发表时间:
    2001-01-01
  • 期刊:
  • 影响因子:
    1.900
  • 作者:
    Jurriaan Ton;Sylke Davison;Leendert C. Van Loon;Corné M.J. Pieterse
  • 通讯作者:
    Corné M.J. Pieterse
Decoding resilience: ecology, regulation, and evolution of biosynthetic gene clusters
解读复原力:生物合成基因簇的生态学、调控机制与进化
  • DOI:
    10.1016/j.tplants.2024.09.008
  • 发表时间:
    2025-02-01
  • 期刊:
  • 影响因子:
    20.800
  • 作者:
    George Lister Cawood;Jurriaan Ton
  • 通讯作者:
    Jurriaan Ton

Jurriaan Ton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jurriaan Ton', 18)}}的其他基金

Exploring and Exploiting Epigenetic Plant Immunity
探索和利用表观遗传植物免疫
  • 批准号:
    BB/W015250/1
  • 财政年份:
    2023
  • 资助金额:
    $ 75.35万
  • 项目类别:
    Research Grant
13 ERA-CAPS: Biosynthesis, transport and exudation of 1,4-benzoxazin-3-ones as determinants of plant biotic interactions
13 ERA-CAPS:1,4-苯并恶嗪-3-酮的生物合成、运输和渗出作为植物生物相互作用的决定因素
  • 批准号:
    BB/L027925/1
  • 财政年份:
    2014
  • 资助金额:
    $ 75.35万
  • 项目类别:
    Research Grant
EXPLORING ADAPTIVE IMMUNITY IN PLANTS
探索植物的适应性免疫
  • 批准号:
    BB/E023959/1
  • 财政年份:
    2008
  • 资助金额:
    $ 75.35万
  • 项目类别:
    Fellowship

相似海外基金

The COVID-19 vaccine efficacy among people living with and without HIV: a real-world data approach
COVID-19 疫苗在艾滋病毒感染者和未感染者中的功效:真实世界数据方法
  • 批准号:
    10547230
  • 财政年份:
    2022
  • 资助金额:
    $ 75.35万
  • 项目类别:
The COVID-19 vaccine efficacy among people living with and without HIV: a real-world data approach
COVID-19 疫苗在艾滋病毒感染者和未感染者中的功效:真实世界数据方法
  • 批准号:
    10640994
  • 财政年份:
    2022
  • 资助金额:
    $ 75.35万
  • 项目类别:
Development of a Novel rAAV Vector Without Cross-species Barrier to Transduce Human and Ferret Conducting Airways
开发一种无跨物种障碍的新型 rAAV 载体来转换人类和雪貂的气道
  • 批准号:
    10430253
  • 财政年份:
    2021
  • 资助金额:
    $ 75.35万
  • 项目类别:
MICA: Seasonal vaccination with the RTS,S/AS01 malaria vaccine given with or without seasonal malaria chemoprevention (SMC): an extension study.
MICA:在有或没有季节性疟疾化学预防 (SMC) 的情况下使用 RTS,S/AS01 疟疾疫苗进行季节性疫苗接种:一项扩展研究。
  • 批准号:
    MR/V005642/1
  • 财政年份:
    2021
  • 资助金额:
    $ 75.35万
  • 项目类别:
    Research Grant
Menstrual health during the Covid-19 pandemic: A longitudinal study among young people with and without endometriosis
Covid-19 大流行期间的月经健康:对患有和不患有子宫内膜异位症的年轻人进行的纵向研究
  • 批准号:
    10434356
  • 财政年份:
    2018
  • 资助金额:
    $ 75.35万
  • 项目类别:
MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa
MTBVAC 1b/2a 期随机、双盲、主动对照、安全性、免疫原性和剂量递增研究,针对南非患有和不患有潜伏性结核感染的成人
  • 批准号:
    9752442
  • 财政年份:
    2017
  • 资助金额:
    $ 75.35万
  • 项目类别:
MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa
MTBVAC 1b/2a 期随机、双盲、主动对照、安全性、免疫原性和剂量递增研究,针对南非患有和不患有潜伏性结核感染的成人
  • 批准号:
    9351292
  • 财政年份:
    2017
  • 资助金额:
    $ 75.35万
  • 项目类别:
Boosting Flu Vaccination without Adjuvant Injection
无需注射佐剂即可加强流感疫苗接种
  • 批准号:
    8263742
  • 财政年份:
    2011
  • 资助金额:
    $ 75.35万
  • 项目类别:
Boosting Flu Vaccination without Adjuvant Injection
无需注射佐剂即可加强流感疫苗接种
  • 批准号:
    8184135
  • 财政年份:
    2011
  • 资助金额:
    $ 75.35万
  • 项目类别:
Boosting Flu Vaccination without Adjuvant Injection
无需注射佐剂即可加强流感疫苗接种
  • 批准号:
    8510563
  • 财政年份:
    2011
  • 资助金额:
    $ 75.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了